Pramlintide CAS:151126-32-8

Pramlintide works by slowing down the rate at which food is digested, reducing post-meal blood sugar spikes, and suppressing glucagon secretion, which helps lower blood sugar levels. The medication is typically administered via subcutaneous injection before meals to complement insulin therapy and improve overall glycemic control. It can also aid in weight management by promoting satiety and reducing food intake, making it a valuable treatment option for patients struggling to achieve target blood sugar levels and maintain a healthy weight.